Gakul Baishya
North East Institute of Science and Technology
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Gakul Baishya.
PLOS ONE | 2012
Soma Seal; Priyajit Chatterjee; Sushmita Bhattacharya; Durba Pal; Suman Dasgupta; Rakesh Kundu; Sandip Mukherjee; Shelley Bhattacharya; Mantu Bhuyan; Pranab R. Bhattacharyya; Gakul Baishya; Nabin C. Barua; Pranab Kumar Baruah; Paruchuri G. Rao; Samir Bhattacharya
Non-small cell lung carcinoma (NSCLC) is a major killer in cancer related human death. Its therapeutic intervention requires superior efficient molecule(s) as it often becomes resistant to present chemotherapy options. Here we report that vapor of volatile oil compounds obtained from Litsea cubeba seeds killed human NSCLC cells, A549, through the induction of apoptosis and cell cycle arrest. Vapor generated from the combined oils (VCO) deactivated Akt, a key player in cancer cell survival and proliferation. Interestingly VCO dephosphorylated Akt at both Ser473 and Thr308; through the suppression of mTOR and pPDK1 respectively. As a consequence of this, diminished phosphorylation of Bad occurred along with the decreased Bcl-xL expression. This subsequently enhanced Bax levels permitting the release of mitochondrial cytochrome c into the cytosol which concomitantly activated caspase 9 and caspase 3 resulting apoptotic cell death. Impairment of Akt activation by VCO also deactivated Mdm2 that effected overexpression of p53 which in turn upregulated p21 expression. This causes enhanced p21 binding to cyclin D1 that halted G1 to S phase progression. Taken together, VCO produces two prong effects on lung cancer cells, it induces apoptosis and blocked cancer cell proliferation, both occurred due to the deactivation of Akt. In addition, it has another crucial advantage: VCO could be directly delivered to lung cancer tissue through inhalation.
Molecular Cancer Therapeutics | 2014
Karishma S Amin; Shankar Jagadeesh; Gakul Baishya; Paruchuri G. Rao; Nabin C. Barua; Samir Bhattacharya; Partha P. Banerjee
Continued reliance on androgen receptor (AR) signaling is a hallmark of prostate cancer, including the development of castration-resistant prostate cancer (CRPC), making it an attractive therapeutic target for prostate cancer treatment. Mahanine is a novel carbazole alkaloid derived from the leaves of Murraya koenigii, commonly known as the curry leaf plant, which grows widely across East-Asia. We show here that mahanine possesses the ability to inhibit ligand-dependent and -independent AR transactivation, leading to a prominent decline in AR target gene expression. Mahanine treatment causes a time- and dose-dependent decline in AR protein levels, including truncated AR splice variants, in a panel of androgen-responsive and -independent prostate cancer cells. The decrease in AR levels induced by mahanine occurs posttranslationally by proteasomal degradation, without any change in the AR gene expression. Mahanine treatment induces an outward movement of the AR from the nucleus to the cytoplasm, leading to an initial increase in cytoplasmic AR levels, followed by a gradual decline in the AR levels in both cellular compartments. Ligand-induced AR phosphorylation at Ser-81, a phospho-site associated with prostate cancer cell growth and AR transactivity, is greatly diminished in the presence of mahanine. The decline in AR phosphorylation at Ser-81 by mahanine occurs via the inactivation of mitotic kinase CDK1. Collectively, our data demonstrate that mahanine strongly disrupts AR signaling and inhibits the growth of androgen-dependent and -independent prostate cancer cells, thereby implicating a therapeutic role of mahanine in prostate cancer treatment. Mol Cancer Ther; 13(2); 341–52. ©2013 AACR.
RSC Advances | 2014
Barnali Sarmah; Gakul Baishya; Rajani K. Baruah
(−)-Isopulegol was subjected to a triflic acid-promoted three-component Prins–Ritter reaction with a series of aldehydes to produce a library of novel 4-acetamido-octahydro-2H-chromene derivatives in good yields and high diastereoselectivities.
Chemistry Letters | 2002
J. S. Yadav; B. V. S. Reddy; Gakul Baishya
Chemistry Letters | 2007
J. S. Yadav; B. V. Subba Reddy; Atla Raju; K. Ravindar; Gakul Baishya
Synlett | 2013
Gakul Baishya; Barnali Sarmah; Nabajyoti Hazarika
Tetrahedron Letters | 2008
Partha Pratim Saikia; Gakul Baishya; Abhishek Goswami; Nabin C. Barua
Chemistry Letters | 2005
J. S. Yadav; B. V. S. Reddy; Gakul Baishya; A. Venkat Narsaiah
Synlett | 2003
J. S. Yadav; B. V. S. Reddy; Gakul Baishya
Synthesis | 2004
J. S. Yadav; B. V. Subba Reddy; Gakul Baishya; P. Venkatram Reddy; S. J. Harshavardhan